Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
2.
BMJ Case Rep ; 12(8)2019 Aug 01.
Article in English | MEDLINE | ID: mdl-31371277

ABSTRACT

A 70-year-old man presented with 1 month of haematuria and mild right-sided flank pain with no other symptoms. Diagnostic workup included serum studies which showed the presence of antimyeloperoxidase antibodies, a kidney biopsy which demonstrated necrotising crescentic glomerulonephritis with linear immunofluorescence of the basement membrane, and electron microscopy which exhibited thickening of the glomerular basement membrane. Incidentally, the patient was discovered to have a latent hepatitis B infection, which complicated immunosuppressive therapy. He was treated with a course of plasmapheresis and methylprednisolone, followed by entecavir for hepatitis B prophylaxis, and finally by rituximab. This case of glomerulonephritis was notable for its resemblance to the better known Goodpasture's disease. Typically, Goodpasture's syndrome exists on a spectrum from seronegative disease to double-positive disease that presents with both anti-glomerular basement membrane (anti-GBM) and cytoplasmic-antineutrophil cytoplasmic antibodies/antiproteinase 3 antibodies (c-ANCA/anti-PR3). However, this patient's glomerulonephritis was unique because he presented negative for anti-GBM antibodies and positive for perinuclear-antineutrophil cytoplasmic antibodies/antimyeloperoxidase antibodies (p-ANCA/anti-MPO).


Subject(s)
Glomerulonephritis/diagnosis , Lung Diseases, Interstitial/diagnosis , Peroxidase/immunology , Aged , Antibodies, Antineutrophil Cytoplasmic/metabolism , Autoantibodies/metabolism , Diagnosis, Differential , Glomerulonephritis/immunology , Glomerulonephritis/therapy , Guanine/analogs & derivatives , Guanine/therapeutic use , Humans , Lung Diseases, Interstitial/immunology , Lung Diseases, Interstitial/therapy , Male , Methylprednisolone/therapeutic use , Microscopy, Electron , Plasmapheresis , Rituximab/therapeutic use , Treatment Outcome
3.
Am J Obstet Gynecol ; 206(3): 236.e1-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22264652

ABSTRACT

OBJECTIVE: Spontaneous labor at term involves the activation of placental corticotropin-releasing hormone and the fetal adrenal axis, but the basis for extreme preterm labor is unknown. Our objective was to determine whether placental corticotropin-releasing hormone is activated in extreme preterm labor. STUDY DESIGN: One thousand five hundred six mothers delivering at less than 28 weeks' gestation were enrolled. Each mother/infant pair was assigned to the category that described the primary reason for hospitalization. Observers who had no knowledge of patient categorization assessed placenta microbiology, histology, and corticotropin-releasing hormone expression. These were correlated with the primary reason for hospitalization. RESULTS: Among infants delivered at less than 28 weeks' gestation, spontaneous (vs induced) delivery was associated with less placental corticotropin-releasing hormone expression and more frequent signs of placental inflammation and infection. CONCLUSION: Inflammation and infection, rather than premature activation of the fetal adrenal axis, should be the major focus of research to prevent extremely preterm human birth.


Subject(s)
Chorioamnionitis/microbiology , Pregnancy Complications, Infectious/microbiology , Premature Birth/microbiology , Adrenal Glands/metabolism , Cohort Studies , Corticotropin-Releasing Hormone/analysis , Cytokines/blood , Female , Humans , Infant, Newborn , Male , Multicenter Studies as Topic , Placenta/chemistry , Placenta/cytology , Placenta/microbiology , Pregnancy , Pregnancy Outcome
4.
Rev. ciênc. méd., (Campinas) ; 10(1): 28-30, jan.-abr. 2001.
Article in Portuguese | LILACS | ID: lil-322478

ABSTRACT

A mortalidade do Lúpus Eritematoso Sistêmico tem decrescido nos últimos anos pelo diagnóstico precoce e tratamento mais rigoroso com corticóides e imunossupressores. Estes, por sua vez, levam a uma diminuiçäo da imunidade, deixando o paciente mais suscetível aos agentes infecciosos que têm atualmente um papel importante entre as causas de mortes em pacientes lúpicos. Os autores descrevem o caso de uma paciente lúpica que evoluiu para morte após maningite criptococócica e infecçöes de repetiçäo.


Subject(s)
Humans , Female , Opportunistic Infections/complications , Lupus Erythematosus, Systemic/complications , Meningitis, Cryptococcal/complications , Immunosuppression Therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...